Cargando…
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2
PURPOSE: Missing scores complicate analysis of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) because patients with and without missing scores may systematically differ. We focus on optimal analysis methods for incomplete PRO-CTCAE items, with...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859007/ https://www.ncbi.nlm.nih.gov/pubmed/34420143 http://dx.doi.org/10.1007/s11136-021-02968-1 |
_version_ | 1784654358227451904 |
---|---|
author | Mazza, Gina L. Petersen, Molly M. Ginos, Brenda Langlais, Blake T. Heon, Narre Gounder, Mrinal M. Mahoney, Michelle R. Zoroufy, Alexander J. Schwartz, Gary K. Rogak, Lauren J. Thanarajasingam, Gita Basch, Ethan Dueck, Amylou C. |
author_facet | Mazza, Gina L. Petersen, Molly M. Ginos, Brenda Langlais, Blake T. Heon, Narre Gounder, Mrinal M. Mahoney, Michelle R. Zoroufy, Alexander J. Schwartz, Gary K. Rogak, Lauren J. Thanarajasingam, Gita Basch, Ethan Dueck, Amylou C. |
author_sort | Mazza, Gina L. |
collection | PubMed |
description | PURPOSE: Missing scores complicate analysis of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) because patients with and without missing scores may systematically differ. We focus on optimal analysis methods for incomplete PRO-CTCAE items, with application to two randomized, double-blind, placebo-controlled, phase III trials. METHODS: In Alliance A091105 and COMET-2, patients completed PRO-CTCAE items before randomization and several times post-randomization (N = 64 and 107, respectively). For each trial, we conducted between-arm comparisons on the PRO-CTCAE via complete-case two-sample t-tests, mixed modeling with contrast, and multiple imputation followed by two-sample t-tests. Because interest lies in whether CTCAE grades can inform missing PRO-CTCAE scores, we performed multiple imputation with and without CTCAE grades as auxiliary variables to assess the added benefit of including them in the imputation model relative to only including PRO-CTCAE scores across all cycles. RESULTS: PRO-CTCAE completion rates ranged from 100.0 to 71.4% and 100.0 to 77.1% across time in A091105 and COMET-2, respectively. In both trials, mixed modeling and multiple imputation provided the most similar estimates of the average treatment effects. Including CTCAE grades in the imputation model did not consistently narrow confidence intervals of the average treatment effects because correlations for the same PRO-CTCAE item between different cycles were generally stronger than correlations between each PRO-CTCAE item and its corresponding CTCAE grade at the same cycle. CONCLUSION: For between-arm comparisons, mixed modeling and multiple imputation are informative techniques for handling missing PRO-CTCAE scores. CTCAE grades do not provide added benefit for informing missing PRO-CTCAE scores. ClinicalTrials.gov Identifiers: NCT02066181 (Alliance A091105); NCT01522443 (COMET-2). |
format | Online Article Text |
id | pubmed-8859007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88590072022-04-07 Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 Mazza, Gina L. Petersen, Molly M. Ginos, Brenda Langlais, Blake T. Heon, Narre Gounder, Mrinal M. Mahoney, Michelle R. Zoroufy, Alexander J. Schwartz, Gary K. Rogak, Lauren J. Thanarajasingam, Gita Basch, Ethan Dueck, Amylou C. Qual Life Res Article PURPOSE: Missing scores complicate analysis of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) because patients with and without missing scores may systematically differ. We focus on optimal analysis methods for incomplete PRO-CTCAE items, with application to two randomized, double-blind, placebo-controlled, phase III trials. METHODS: In Alliance A091105 and COMET-2, patients completed PRO-CTCAE items before randomization and several times post-randomization (N = 64 and 107, respectively). For each trial, we conducted between-arm comparisons on the PRO-CTCAE via complete-case two-sample t-tests, mixed modeling with contrast, and multiple imputation followed by two-sample t-tests. Because interest lies in whether CTCAE grades can inform missing PRO-CTCAE scores, we performed multiple imputation with and without CTCAE grades as auxiliary variables to assess the added benefit of including them in the imputation model relative to only including PRO-CTCAE scores across all cycles. RESULTS: PRO-CTCAE completion rates ranged from 100.0 to 71.4% and 100.0 to 77.1% across time in A091105 and COMET-2, respectively. In both trials, mixed modeling and multiple imputation provided the most similar estimates of the average treatment effects. Including CTCAE grades in the imputation model did not consistently narrow confidence intervals of the average treatment effects because correlations for the same PRO-CTCAE item between different cycles were generally stronger than correlations between each PRO-CTCAE item and its corresponding CTCAE grade at the same cycle. CONCLUSION: For between-arm comparisons, mixed modeling and multiple imputation are informative techniques for handling missing PRO-CTCAE scores. CTCAE grades do not provide added benefit for informing missing PRO-CTCAE scores. ClinicalTrials.gov Identifiers: NCT02066181 (Alliance A091105); NCT01522443 (COMET-2). Springer International Publishing 2021-08-21 2022 /pmc/articles/PMC8859007/ /pubmed/34420143 http://dx.doi.org/10.1007/s11136-021-02968-1 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Mazza, Gina L. Petersen, Molly M. Ginos, Brenda Langlais, Blake T. Heon, Narre Gounder, Mrinal M. Mahoney, Michelle R. Zoroufy, Alexander J. Schwartz, Gary K. Rogak, Lauren J. Thanarajasingam, Gita Basch, Ethan Dueck, Amylou C. Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 |
title | Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 |
title_full | Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 |
title_fullStr | Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 |
title_full_unstemmed | Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 |
title_short | Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2 |
title_sort | missing data strategies for the patient-reported outcomes version of the common terminology criteria for adverse events (pro-ctcae) in alliance a091105 and comet-2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859007/ https://www.ncbi.nlm.nih.gov/pubmed/34420143 http://dx.doi.org/10.1007/s11136-021-02968-1 |
work_keys_str_mv | AT mazzaginal missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT petersenmollym missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT ginosbrenda missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT langlaisblaket missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT heonnarre missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT goundermrinalm missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT mahoneymicheller missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT zoroufyalexanderj missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT schwartzgaryk missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT rogaklaurenj missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT thanarajasingamgita missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT baschethan missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 AT dueckamylouc missingdatastrategiesforthepatientreportedoutcomesversionofthecommonterminologycriteriaforadverseeventsproctcaeinalliancea091105andcomet2 |